SCHEMBL29207253

SCHEMBL29207253

C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)NCCN)CC[C@@H]12

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 15/20 0.72
SRD5A2 P31213 6/20 0.72
LMNA P02545 2/20 0.72
CYP3A4 P08684 2/20 0.72
CYP2C9 P11712 2/20 0.72
CYP2C19 P33261 2/20 0.72
ABCC4 O15439 1/20 0.72
ABCB11 O95342 1/20 0.72
ADORA3 P0DMS8 1/20 0.72
CHRM1 P11229 1/20 0.72
HSD3B1 P14060 1/20 0.72
NFKB1 P19838 1/20 0.72
MAPK1 P28482 1/20 0.72
THPO P40225 1/20 0.72
BLM P54132 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29207254 0.93 SRD5A1 (0.67) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL728009 0.90 SRD5A1 (0.70) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL11002519 0.89 SRD5A1 (0.75) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL11002514 0.89 SRD5A1 (0.75) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL2292732 0.88 SRD5A1 (0.68) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL8571744 0.88 SRD5A1 (0.68) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL2292737 0.88 SRD5A1 (0.68) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL8722392 0.88 SRD5A1 (0.68) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL9392062 0.87 SRD5A1 (0.72) SRD5A1SRD5A2LMNACYP3A4CYP2C9
SCHEMBL2294373 0.87 SRD5A1 (0.78) SRD5A1SRD5A2LMNACYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118119598-A Medicine for treating human tumor by eRF3a targeting protein degradation mechanism 苏州德亘生物医药有限公司 2024-05-31 CN disclosed
CN-117801051-A Medicine for treating human tumor by eRF3a targeting protein degradation mechanism 苏州德亘生物医药有限公司 2024-04-02 CN disclosed